Stock Events

Stock Events

Akili

$0.43

16

-$0-0.62% Monday 20:00

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

9MayExpected

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.31

0.05

0.4

0.76

Expected EPS

-0.17

Actual EPS

0

Financials

-3,545.47%Profit Margin

Unprofitable

2021

2022

2023

1.68MRevenue

-59.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AKLI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Take-Two Interactive Software

Take-Two Interactive, through its subsidiary Zynga, develops games that could be adapted for cognitive enhancement, similar to Akili's approach.

Electronic Arts

Electronic Arts develops engaging video games that could pivot towards therapeutic uses, directly competing with Akili's digital treatment platforms.

Zoom Communications

Zoom Video Communications could facilitate remote digital therapy sessions, offering a platform that competes with Akili's remote treatment options.

Peloton Interactive

Peloton Interactive, known for its interactive fitness products, could expand into wellness and mental health, competing with Akili's cognitive treatment solutions.

Teladoc Health offers virtual healthcare services, including mental health solutions that could compete with Akili's digital therapeutics for cognitive disorders.

Omnicell provides automation and business analytics for healthcare, and its expansion into digital health solutions could compete with Akili's offerings.

Match Group, through its social and dating platforms, could venture into mental wellness apps, indirectly competing with Akili's focus on cognitive health.

Roku, as a streaming platform, has the potential to deliver therapeutic content, including cognitive training programs, competing with Akili's digital therapies.

Google, with its vast resources and interest in health technologies, could develop or acquire digital therapeutic applications, directly competing with Akili's cognitive treatments.

About

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Show more...

CEO

Employees

68

Country

United States

ISIN

US00974B1070

Listings

0 Comments

Share your thoughts

FAQ

What is Akili stock price today?▼

The current price of AKLI is $0.43 USD — it has decreased by -0.62% in the past 24 hours. Watch Akili stock price performance more closely on the chart.

What is Akili stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Akili stocks are traded under the ticker AKLI.

What were Akili earnings last quarter?▼

AKLI earnings for the last quarter are 0 USD per share, whereas the estimation was -0.17 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Akili revenue for the last year?▼

Akili revenue for the last year amounts to 1.68M USD.

What is Akili net income for the last year?▼

AKLI net income for the last year is -59.49M USD.

How many employees does Akili have?▼

As of April 14, 2026, the company has 68 employees.

In which sector is Akili located?▼

Akili operates in the Communication sector.

When did Akili complete a stock split?▼

Akili has not had any recent stock splits.